Business Context and Reporting Period
Company: Braskem S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Third Quarter 2025 (Ended September 30, 2025)
Context: The filing summarizes the 3Q25 earnings conference call held on November 11, 2025. Braskem operates in a prolonged petrochemical downcycle characterized by global macroeconomic volatility, excess supply, and soft demand across all regions.
Key Financial Metrics
- Recurring EBITDA: US$150 million for 3Q25, representing a 104% increase versus 2Q25 but a 65% decrease versus 3Q24.
- Recurring EBITDA Margin: 4.7% (down 9 percentage points from 3Q24).
- Operating Cash Flow: Approximately US$(61) million (negative), an improvement of US$30 million compared to 2Q25.
- Liquidity: Total liquidity of approximately US$2.3 billion (Cash Position of ~US$1.3 billion + Stand-by credit facility).
- Debt Profile: Gross Debt of US$8.4 billion; Adjusted Net Debt of US$7.2 billion. Weighted average cost of debt is 6.29%.
- Debt Maturity: Sufficient liquidity to cover principal maturities for the next 27 months. Approximately 69% of corporate debt matures from 2030 onwards.
- Utilization Rates: Brazil (65%), USA & Europe (47%), Mexico (32%).
Material Changes vs. Prior Period
- EBITDA Improvement: The 104% sequential increase in Recurring EBITDA was driven by the appreciation of the Brazilian Real against the US Dollar, higher sales volumes of main chemicals, and a commercial strategy prioritizing higher value-added products in Brazil.
- Cost Reduction: Fixed costs and SG&A were reduced due to resilience initiatives and reclassification of expenses related to REIQ investments.
- Segment Performance:
- Brazil: Improved due to higher sales of main chemicals and prioritization of value-added sales.
- USA & Europe: Remained impacted by weak demand and pressured spreads, partially offset by lower inventory effects on cost of goods sold.
- Mexico: Impacted by a scheduled maintenance shutdown (completed July 2025) and lower feedstock supply from Pemex, though ethane supply from TQPM began in September 2025.
- Cash Flow: Significant cash consumption of R$1,476 million (approx. US$280 million) in 3Q25, driven by the Alagoas geological event provisions, CAPEX, and semiannual interest payments.
Guidance, Outlook, and Risks
- Outlook: Management expects the prolonged petrochemical downcycle to extend until the end of the decade, with only a modest recovery projected after 2029. Global trade tensions and protectionist policies remain key uncertainties.
- Strategic Priorities:
- Implementation of the "Resilience and Transformation Program" with over 700 initiatives targeting US$400 million in EBITDA and US$500 million in cash capture.
- Transformation of the Alagoas chlor-alkali plant to handle dichloroethane (EDC) to improve PVC competitiveness.
- Expansion of the Rio de Janeiro gas-based cracker (approved Oct 2025) to add 220 kton/year of ethylene capacity, with completion expected by end of 2028.
- Alagoas Contingency: Total provisions related to the Alagoas geological event stand at R$18.1 billion. As of September 2025, R$13.6 billion has been disbursed, with a remaining net balance of approximately R$3.8 billion. The company cannot rule out future developments or additional costs.
- Liquidity Management: In October 2025, the company drew down its US$1.0 billion stand-by credit line to reinforce liquidity in the face of the downcycle.
Investor Verification Checklist
- Verify the sustainability of the 104% sequential EBITDA growth given the continued pressure on global petrochemical spreads.
- Monitor the execution and cost implications of the Alagoas geological event remediation and the R$3.8 billion remaining provision balance.
- Assess the impact of the Mexico segment's restart and the new TQPM ethane supply on future utilization rates and margins.
- Track the progress of the "Resilience and Transformation Program" initiatives against the US$400 million EBITDA target.
- Review the financing status and regulatory approvals for the Rio de Janeiro cracker expansion project (estimated investment ~R$4.2 billion).